Skip to Content

JSP 545 (Digoxin 250 mcg (0.25 mg))

Pill with imprint JSP 545 is White, Round and has been identified as Digoxin 250 mcg (0.25 mg). It is supplied by Lannett Company, Inc..

Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 250 mcg (0.25 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for JSP 545

Digoxin 250 mcg (0.25 mg) JSP 545
Digoxin 250 mcg (0.25 mg) JSP 545  Front
Digoxin 250 mcg (0.25 mg) JSP 545  Back
Digoxin 250 mcg (0.25 mg) JSP 545

Digoxin

Imprint:
JSP 545
Strength:
250 mcg (0.25 mg)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Group V antiarrhythmics
Inotropic agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Lannett Company, Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
stearic acid
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide